EC
STTK icon

EntryPoint Capital’s Shattuck Labs STTK Stock Holding History

EntryPoint Capital’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$183K Buy
+26,387
New +$165K 0.04% 702

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EntryPoint Capital's STTK Position: Q2 2026 in Review

EntryPoint Capital opened a new position in Shattuck Labs (STTK) in Q2 2026: 26,387 shares worth $183K. The stake represents 0.04% of the portfolio and ranks #702 among its holdings.

100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • EntryPoint Capital held 26,387 shares of Shattuck Labs worth $183K as of Q2 2026.
  • Shattuck Labs was a new EntryPoint Capital position in Q2 2026.
  • Shattuck Labs made up 0.04% of EntryPoint Capital's portfolio in Q2 2026, its #702 holding.
  • 100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.